These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1418336)

  • 41. Caffeine study.
    Lechat MF; Borlee I; Bouckaert A; Misson C
    Science; 1980 Mar; 207(4437):1296-7. PubMed ID: 7355288
    [No Abstract]   [Full Text] [Related]  

  • 42. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists.
    James L; Barnes TR; Lelliott P; Taylor D; Paton C
    J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Teratogenic potential of vaginal metronidazole treatment during pregnancy.
    Kazy Z; Puhó E; Czeizel AE
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):174-8. PubMed ID: 16316810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction in frequency of fetopathic effects of caffeine in mice by pretreatment with propranolol.
    Fujii T; Nishimura H
    Teratology; 1974 Oct; 10(2):149-52. PubMed ID: 4473845
    [No Abstract]   [Full Text] [Related]  

  • 45. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregnancy outcome following exposure to permethrin and use of teratogen information.
    Kennedy D; Hurst V; Konradsdottir E; Einarson A
    Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemicals which cause birth defects--teratogens: a special concern of research chemists.
    Meyers VK
    Sci Total Environ; 1983 Dec; 32(1):1-12. PubMed ID: 6665552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Identification of teratogenic risk factors by a case-control approach].
    Calzolari E
    Pathologica; 1986; 78(1058):803-7. PubMed ID: 3696789
    [No Abstract]   [Full Text] [Related]  

  • 49. Teratogenesis and drugs for rheumatic disease.
    le Gallez P
    Nurs Times; 1988 Jul 6-12; 84(27):41-4. PubMed ID: 3405833
    [No Abstract]   [Full Text] [Related]  

  • 50. [Formation of abnormalities--teratogenesis].
    Neuhäuser G
    Hippokrates; 1976 May; 47(2):162-3. PubMed ID: 965246
    [No Abstract]   [Full Text] [Related]  

  • 51. A rational approach to drug use in pregnancy.
    Zacharias J
    JOGN Nurs; 1983; 12(3):183-7. PubMed ID: 6553108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [APROPOS OF THE TERATOGENIC ACTION OF DRUGS. DIFFICULTIES UNDER PRESENT CIRCUMSTANCES OF VERIFYING A MEDICAMENTOUS ETIOLOGY. PERSONAL OBSERVATION OF AN AGENESIS OF THE RIGHT HAND].
    NOTTER A; ROBERT JM
    Lyon Med; 1963 Dec; 210():1339-57. PubMed ID: 14103609
    [No Abstract]   [Full Text] [Related]  

  • 53. [Centre de référence sur les agents tératogènes (CRAT): a pioneer center].
    Elefant E; Vauzelle C; Beghin D
    Therapie; 2014; 69(1):39-45. PubMed ID: 24698187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial In Bed with The Devil: Recognizing Human Teratogenic Exposures.
    Friedman JM
    Birth Defects Res; 2017 Nov; 109(18):1407-1413. PubMed ID: 29152923
    [No Abstract]   [Full Text] [Related]  

  • 55. Counseling pregnant women exposed to potentially harmful agents during pregnancy.
    Shepard TH
    Clin Obstet Gynecol; 1983 Jun; 26(2):478-83. PubMed ID: 6851295
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of surveillance in monitoring reproductive health.
    Rosenberg MJ; Halperin WE
    Teratog Carcinog Mutagen; 1984; 4(1):15-24. PubMed ID: 6143418
    [No Abstract]   [Full Text] [Related]  

  • 57. [Meprobamate and chlordiazepoxide, teratogenic effect?].
    Ugeskr Laeger; 1975 Apr; 137(18):1017-8. PubMed ID: 1145819
    [No Abstract]   [Full Text] [Related]  

  • 58. Teratogens.
    Stevenson AM
    MCN Am J Matern Child Nurs; 1998; 23(6):333. PubMed ID: 9819526
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction of malformations by actinomycin D at mid-pregnancy in the rat and protection by L-thyroxine.
    Harvey JE; Srebnik HH
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):553-5. PubMed ID: 652792
    [No Abstract]   [Full Text] [Related]  

  • 60. [Toxicity of drugs in the fetus and the newborn. I. Teratogenic agents].
    Reginster L
    Rev Med Liege; 1966 Sep; 21(18):441-6 contd. PubMed ID: 5341662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.